期刊文献+

心血管因素及血清高半胱氨酸水平升高与脑梗死患者死亡风险的相关分析 被引量:4

Correlation between cardiovascular factors,elevated serum homocysteine level and death risk in patients with cerebral infarction
下载PDF
导出
摘要 目的探讨心血管因素及血清高半胱氨酸(Hcy)水平升高与脑梗死患者1年死亡风险的相关性。方法回顾性分析369例脑梗死患者临床资料及1年内生存情况。用χ2检验分析正常组和异常组死亡率差异,单因素Cox比例风险回归分析各危险因素的风险比,并绘制累计死亡曲线。结果心脏形态异常、颈动脉斑块形成及血清Hcy水平升高患者的死亡率较对照组增高(P<0.05)。单因素Cox风险比例回归分析显示心脏形态异常、颈动脉斑块形成以及Hcy水平升高均与患者1年死亡风险增高相关(P<0.05)。结论脑梗死患者心脏形态异常、颈动脉斑块形成及血清Hcy高水平可增加脑梗死患者1年内死亡风险。 Objective To evaluate the corelation between cardiovascular factors, elevated serum homocysteine (Hcy) level and death risk in patients with cerebral infarction(CI) within one year after onset. Methods A hospital-based cohort of 369 consecutive CI patients was reviewed retrospectively. The mortality difference between abnormal group and normal group (control) was distinguished by Chi-square test, and odds ratio estimates were calculated according to univariate Cox's Proportional Hazard Regression analysis. A cumulative hazard curve was plotted in order to explore the mortality difference between the two groups. Results The mortality in the patients with abnormalities of cardiac structure, carotid atherosclerosis and elevated serum Hcy was higher than the normal group ( P 〈 0.05 ). The univariate Cox's Proportional Hazard Regression analysis indicated abnormalities of cardiac structure, carotid atherosclerosis and elevated serum Hcy correlated with elevated death risk in one year ( P 〈 0.05 ). Conclusion The abnormalities of cardiac structure, carotid atheroselerosis and elevated serum Hey level may significantly increase the risk of death of CI patients.
出处 《临床检验杂志》 CAS CSCD 北大核心 2014年第6期426-428,共3页 Chinese Journal of Clinical Laboratory Science
基金 教育部新教师基金(20111107120015)
关键词 脑梗死 心血管疾病 颈动脉斑块 高半胱氨酸 死亡率 预测因子 cerebral infarction cardiovascular disease carotid atheroselerosis elevated serum homocysteine level mortality predictor
  • 相关文献

参考文献3

二级参考文献51

  • 1[1]McCully K S.Homocysteine and vascular disease [J].Nat Med,1996,2(4):386-389.
  • 2[2]Warren C J.What is homocysteine [J]? AM J Nurs,1999,99(10):39-41.
  • 3[3]Ueland P M,Refsum H,Stabler S P,et al.Total homocysteine in plasma or serum:methods and clinical applications[J].Clin Chem,1993,39(9):1764-1779.
  • 4[4]Frank F, Arne L F, Ingrid A,et al.Enzyme conversion immunoassay for determining total homocysteine in plasma or serum[J].Clin Chem,1998,44(2):311-316.
  • 5[5]Vecchione G,Margaglione M,Grandone E,et al.Determining sulfor-containing amino acids by capillary electrophoresis:a fast novel method for total homocysteine human plasma[J].Electrophoresis,1999,20(3):569-574.
  • 6[6]Ducros V,Schmitt D,Pernod G,et al.Gas chromatographic-mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution:method and clinical applications[J].J Chromatogr B,1999,729(1-2):333-339.
  • 7[7]Magera M J,Lacey J M,Casetta B,et al.Method for the determination of total homocysteine in plasma and using by stable isotope dilution and electrospray tandem mass spectrometry[J].Clin Chem,1999,45(9):1517-1522.
  • 8[8]Pfeiffer C M,Twite D,Shih J,et al.Method comparison for total plasma homocysteine between the Abbott Imx analyzer and an HPLC assay with internal standardization[J].Clin Chem,1999,45(1):152-153.
  • 9[9]Frantzen F,Faaren A L,Alfheim I,et al.Enzyme conversion immunoassay for determining total homocysteine in plasma or serum[J].Clin Chem,1998,44(2):311-316.
  • 10[10]Pastore Renato M,Corradion M,et al.Fully automated assay for total homocysteine, cysteine, cysteinglycine, glutathione, cysteamine, and 2-mercaptopropionylglucine in plasma and urine[J].Clin Chem,1998,44(4):825-832.

共引文献19

同被引文献33

  • 1黄海威,郭明辉,黄家星,林锐金,张颖,陈亚利.1020名社区人群同型半胱氨酸水平的调查和相关分析[J].中华流行病学杂志,2006,27(8):721-724. 被引量:42
  • 2赵建国,高长玉,顼宝玉,孙怡,韩景献.脑梗死和脑出血中西医结合诊断标准(试行)[J].中国中西医结合杂志,2006,26(10):948-949. 被引量:559
  • 3Clarke R, Halsey J, Bennett D, et al. Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis,2011,34( 1 ) : 83-91.
  • 4McNulty H,Pentieva K, Hoey L, et al. Homoeysteine, B-vitamins and CVD. Proc Nutr Soe ,2008,67(2) :232-237.
  • 5de Bree A, Verschuren W M, Biota H J, et al. Association between B vitamin intake and plasma homocysteinc concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr, 2001,73 ( 6 ) : 1027-1033.
  • 6Refsum H, Nurk E, Smith A D, et al. The Hordaland Homocysteine Study: A community- based study of homocysteine, its determinants, and associations with disease. J Nutr, 2006, 136 (6S): 1731 S- 1740S.
  • 7Refsum H, Smith A D, Ueland P M, et al. Facts and recommendations about total homocysteine determinations: An expert opinion. Clin Chem,2004,50 ( 1 ) :3-32.
  • 8Clinical and Laboratory Standard Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. Proposed Guideline-Third Edition. CLSI, Wayno PA USA : 2008.
  • 9Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke : A meta- analysis. JAMA, 2002, 288(16) :2015-2022.
  • 10Hao L, Ma J, Zhu J, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr,2007,137(2) : 407-413.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部